Literature DB >> 23228347

The protective effects of T cell deficiency against brain injury are ischemic model-dependent in rats.

Xiaoxing Xiong1, Lijuan Gu, Hongfei Zhang, Baohui Xu, Shengmei Zhu, Heng Zhao.   

Abstract

Previous studies have reported that T cell deficiency reduced infarct sizes after transient middle cerebral artery (MCA) suture occlusion in mice. However, how reperfusion and different models affect the detrimental effects of T cells have not been studied. We investigated the effects of T cell deficiency in nude rats using two stroke models and compared their infarct sizes with those in WT rats. In the distal MCA occlusion (MCAo) model, the distal MCA was permanently occluded and the bilateral common carotid arteries (CCAs) were transiently occluded for 60 min. In the suture MCAo model, the MCA was transiently occluded for 100 min by the insertion of a monofilament suture. Our results showed that T cell deficiency resulted in about a 50% reduction in infarct size in the suture MCAo model, whereas it had no effect in the distal MCAo model, suggesting the protective effects of T cell deficiency are dependent on the ischemic model used. We further found more total T cells, CD4 T cells and CD8 T cells in the ischemic brains of WT rats in the suture MCAo model than in the distal MCAo model. In addition, we detected more CD68-expressing macrophages in the ischemic brains of WT rats than in nude rats in the suture MCAo but not the distal MCAo model. Lymphocyte reconstitution in nude rats resulted in larger infarct sizes in the suture MCAo, but not in the distal MCAo stroke model. The results of regional CBF measurement indicated a total reperfusion in the MCAo model but only a partial reperfusion in the distal MCAo model. In conclusion, the protective effects of T cell deficiency on brain injury are dependent on the ischemic model used; likely associated with different degrees of reperfusion.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23228347      PMCID: PMC3581747          DOI: 10.1016/j.neuint.2012.11.016

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  22 in total

1.  Role of T lymphocytes and interferon-gamma in ischemic stroke.

Authors:  Gokhan Yilmaz; Thiruma V Arumugam; Karen Y Stokes; D Neil Granger
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

Review 2.  Role of oxidants in ischemic brain damage.

Authors:  P H Chan
Journal:  Stroke       Date:  1996-06       Impact factor: 7.914

3.  Frontal brain asymmetry and immune function.

Authors:  D H Kang; R J Davidson; C L Coe; R E Wheeler; A J Tomarken; W B Ershler
Journal:  Behav Neurosci       Date:  1991-12       Impact factor: 1.912

4.  Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement.

Authors:  A V Alexandrov; W S Burgin; A M Demchuk; A El-Mitwalli; J C Grotta
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

5.  Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice.

Authors:  Lijuan Gu; Xiaoxing Xiong; Hongfei Zhang; Baohui Xu; Gary K Steinberg; Heng Zhao
Journal:  Stroke       Date:  2012-06-07       Impact factor: 7.914

6.  Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats.

Authors:  Heng Zhao; Takayoshi Shimohata; Jade Q Wang; Guohua Sun; David W Schaal; Robert M Sapolsky; Gary K Steinberg
Journal:  J Neurosci       Date:  2005-10-19       Impact factor: 6.167

7.  Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome C release.

Authors:  Heng Zhao; Midori A Yenari; Robert M Sapolsky; Gary K Steinberg
Journal:  Stroke       Date:  2004-01-15       Impact factor: 7.914

8.  Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.

Authors:  T Neumann-Haefelin; R du Mesnil de Rochemont; J B Fiebach; A Gass; C Nolte; T Kucinski; J Rother; M Siebler; O C Singer; K Szabo; A Villringer; P D Schellinger
Journal:  Stroke       Date:  2003-12-11       Impact factor: 7.914

9.  Magnetic fields, brain and immunity: effect on humoral and cell-mediated immune responses.

Authors:  B D Janković; D Marić; J Ranin; J Veljić
Journal:  Int J Neurosci       Date:  1991-07       Impact factor: 2.292

10.  A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.

Authors:  S T Chen; C Y Hsu; E L Hogan; H Maricq; J D Balentine
Journal:  Stroke       Date:  1986 Jul-Aug       Impact factor: 7.914

View more
  24 in total

Review 1.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

2.  Silencing the lncRNA Maclpil in pro-inflammatory macrophages attenuates acute experimental ischemic stroke via LCP1 in mice.

Authors:  Yan Wang; Ying Luo; Yang Yao; Yuhua Ji; Liangshu Feng; Fang Du; Xiaoya Zheng; Tao Tao; Xuan Zhai; Yaning Li; Pei Han; Baohui Xu; Heng Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-21       Impact factor: 6.200

Review 3.  The use of microRNAs to modulate redox and immune response to stroke.

Authors:  Yi-Bing Ouyang; Creed M Stary; Robin E White; Rona G Giffard
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

Review 4.  Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?

Authors:  Aditya Rayasam; Martin Hsu; Julie A Kijak; Lee Kissel; Gianna Hernandez; Matyas Sandor; Zsuzsanna Fabry
Journal:  Immunology       Date:  2018-03-26       Impact factor: 7.397

5.  IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice.

Authors:  Xiaoxing Xiong; Lijun Xu; Liang Wei; Robin E White; Yi-Bing Ouyang; Rona G Giffard
Journal:  Stroke       Date:  2015-06-30       Impact factor: 7.914

6.  Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice.

Authors:  Xiao-Xing Xiong; Li-Juan Gu; Jian Shen; Xian-Hui Kang; Yue-Ying Zheng; Si-Biao Yue; Sheng-Mei Zhu
Journal:  Neurochem Res       Date:  2013-12-07       Impact factor: 3.996

7.  PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways.

Authors:  Xiaoxing Xiong; Rong Xie; Hongfei Zhang; Lijuan Gu; Weiying Xie; Michelle Cheng; Zhihong Jian; Kristina Kovacina; Heng Zhao
Journal:  Neurobiol Dis       Date:  2014-02-27       Impact factor: 5.996

8.  Ischemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in mice.

Authors:  S P Joo; W Xie; X Xiong; B Xu; H Zhao
Journal:  Neuroscience       Date:  2013-04-13       Impact factor: 3.590

9.  Ischemic post-conditioning facilitates brain recovery after stroke by promoting Akt/mTOR activity in nude rats.

Authors:  Rong Xie; Peng Wang; Xunming Ji; Heng Zhao
Journal:  J Neurochem       Date:  2013-07-08       Impact factor: 5.372

Review 10.  T Cells and Cerebral Ischemic Stroke.

Authors:  Lijuan Gu; Zhihong Jian; Creed Stary; Xiaoxing Xiong
Journal:  Neurochem Res       Date:  2015-07-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.